<?xml version="1.0" encoding="us-ascii"?><rss version="2.0"><channel><title>Biopharm Reports Market Research Reports</title><link>http://www.marketreportsonline.com/</link><description>Market Reports Online  XML Feed</description><item><title>Lung Cancer Therapeutic Antibodies: Pipeline, Strategies and Clinical</title><link>http://www.marketreportsonline.com/131823-lung-cancer-thera.html</link><description>This report provides a comprehensive review of 27 candidate therapeutic antibodies that are being evaluated for the treatment of lung cancer; covering pipeline, disease-targeting strategies and clinical findings. These antibodies are directed at 17 potential targets. Globally, lung cancer is the most common cancer and in 2008 there were an estimated 1.6 million new cases and 1.4 million deaths (almost 20% of all cancer deaths) caused by this disease. Five-year survival rates are also low (15-20%) compared to other common cancers. In the US, studies have shown that lung cancer-care cost...</description><pubDate>Sat, 01 Oct 2011 00:00:00 GMT</pubDate></item></channel></rss>